HIV/AIDS Background information for medical media outside the US only This selection gives an overview on background material for HIV/AIDS available on the Boehringer Ingelheim corporate website.

News Releases

• 22.07.2009Head-to-head trial demonstrates Viramune® 's similar efficacy and superior effect on lipid profile compared to atazanavir/ritonavir
• 04 August 2008New data shows HIV therapy tipranavir (Aptivus®) is effective and well tolerated in children
• 28 April 2008European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus®)
• 12 February 2008Boehringer Ingelheim initiates new HIV/AIDS Trial for extended release formulation of Viramune®
• news release archive

Documents

• Poster: New clinical data from ARTEN study - PDF (1 MB)
• Backgrounder: ARTEN Study - July 2009 - PDF (77 KB)
• Backgrounder: VIRAMUNE® (Nevirapine) - July 2009 - PDF (154 KB)
• Backgrounder: HIV Epidemiology and History - July 2009 - PDF (132 KB)
• Fact sheet: HIV and Women (for non-US Media only) - Aug. 2008 - PDF (80 KB)
• Backgrounder: APTIVUS® (Tipranavir) - Aug. 2008 - PDF (137 KB)

Media Resources

• Videos with further insight: "Poster presentation: 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia 2009: Results of the HIV head-to-head study ARTEN."
• On demand webcast: Media roundtable "Women Living Positive", 23 July 2007 at the 2007 IAS Conference in Sydney, Australia. (for non-US Media only)
• Audiocast: Offered by the International AIDS Society (IAS) - Interview between a German HIV-specialist and a journalist about a survey amongst treatment-experienced HIV-patients. (for non-US Media only)